Michael D. Cameron

The Scripps Research Institute - Department of Chemistry

SCHOLARLY PAPERS

3

DOWNLOADS

65

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Development of a Zn 2+-Chelating But Highly Selective Matrix Metalloproteinase 13 Inhibitor

Number of pages: 20 Posted: 19 Apr 2022
Rita Fuerst, Jun Yong Choi, Anna M. Knapinska, Michael D. Cameron, Claudia Ruiz, Amber Eliason, Mark S. Sundrud, Gregg B. Fields and William R. Roush
The Scripps Research Institute - Department of Chemistry, The Scripps Research Institute - Department of Chemistry, Florida Atlantic University, The Scripps Research Institute - Department of Chemistry, The Scripps Research Institute - Department of Chemistry, The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Immunology and Microbiology, Florida Atlantic University and The Scripps Research Institute - Department of Chemistry
Downloads 28 (866,298)

Abstract:

Loading...

Matrix metalloproteinase 13, Structure-activity relationship, collagenolysis inhibition, in vitro and in vivo pharmacokinetics, oxetane containing inhibitors

2.

Development of a Zn2+-Chelating But Highly Selective Matrix Metalloproteinase 13 Inhibitor

Number of pages: 21 Posted: 30 Jul 2022
Rita Fuerst, Jun Yong Choi, Anna M. Knapinska, Michael D. Cameron, Claudia Ruiz, Amber Eliason, Mark S. Sundrud, Gregg B. Fields and William R. Roush
The Scripps Research Institute - Department of Chemistry, The Scripps Research Institute - Department of Chemistry, Florida Atlantic University, The Scripps Research Institute - Department of Chemistry, The Scripps Research Institute - Department of Chemistry, The Scripps Research Institute, The Scripps Research Institute - Department of Immunology and Microbiology, Florida Atlantic University and The Scripps Research Institute - Department of Chemistry
Downloads 20 (940,839)

Abstract:

Loading...

Matrix metalloproteinase 13, structure-activity relationship, collagenolysis inhibition, in vitro and in vivo pharmacokinetics, oxetane containing inhibitors

3.

Identification and Characterization of a Novel Brain-Penetrant Indoleamine 2,3 Dioxygenase 1 Protein Degrader for Glioblastoma

Number of pages: 77 Posted: 11 Apr 2022
Lakshmi Bollu, Prashant V. Bommi, Paige J. Monsen, Lijie Zhai, Kristen L. Lauing, April Bell, Miri Kim, Erik Ladomersky, Leonidas C. Platanias, Daniela E. Matei, Marcelo G. Bonini, Hidayatullah G. Munshi, Rintaro Hashizume, Jennifer D. Wu, Bin Zhang, C. David James, Peiwen Chen, Masha Kocherginsky, Craig Horbinski, Michael D. Cameron, Arabela A. Grigorescu, Bakhtiar Yamini, Rimas V. Lukas, Gary E. Schiltz and Derek Alan Wainwright
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Loyola University of Chicago - Loyola University Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, The Scripps Research Institute - Department of Chemistry, Northwestern University, University of Chicago, affiliation not provided to SSRN, affiliation not provided to SSRN and Northwestern University Feinberg School of Medicine - Department of Neurological Surgery
Downloads 17 (970,720)

Abstract:

Loading...

IDO, PROTAC, glioma, complement, NF-κB, aging, checkpoint, metabolism, tryptophan, kynurenine, brain tumor, colon cancer, breast, prostate, pancreatic